Uncover the biomarkers you’re searching for with a single workflow solution. biomodal’s multiomic analysis provides both genetic and epigenetic data simultaneously with groundbreaking clarity, precision and speed.
Multiomics analysis offers a deeper understanding of the drivers of cancer. Our technology allows you to bring multiomic analysis to your liquid biopsy and genomic DNA samples using your existing DNA sequencing infrastructure.
Probe and determine the markers of biological age to better understand age-related diseases including Alzheimer’s disease, osteoporosis, type II diabetes and chronic heart disease.
Investigate genome-wide methylation patterns across populations with a single solution and integrated data.
Combining genetic and epigenetic DNA sequencing has the potential to reduce the time taken to detect pregnancy complications and significant genetic and epigenetic variations in a foetus.
Reveal the role of DNA methylation in the most common neurodegenerative diseases, and identify potential targets for promising therapeutics.
Use multiomics analysis to identify targets for promising therapeutics tailored to the genetics and epigenetics of the individual.